Valeda Light Delivery System
Asset
Delivers photobiomodulation light to support mitochondrial function in retinal cells.
- Stage
- Human trials
- Modality
- Device
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Dry age-related macular degeneration
Human trials, Completed, NCT04065490, clinicaltrials.gov, 10 Oct 2026
In the full profile
- Owner and partners2
- Trials1
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 10 Oct 2026, 1 source